This study aims to help people with HIV who are on a common treatment that can increase weight and heart disease risk. It will test if adding the drug dapagliflozin helps with weight loss and heart health more than a placebo. It will also compare two different cholesterol-lowerin…
Phase: PHASE3 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Mar 02, 2026 15:29 UTC